(Q37356306)

19 August 2017

1 reference

title

Chronic myeloid leukemia in Asia (English)

1 reference

19 August 2017

chronic myeloid leukemia

0 references

1 reference

Wing Y Au

1

1 reference

19 August 2017

Priscilla B Caguioa

2

1 reference

19 August 2017

Charles Chuah

3

1 reference

19 August 2017

Szu Chun Hsu

4

1 reference

19 August 2017

Saengsuree Jootar

5

1 reference

19 August 2017

Dong-Wook Kim

6

1 reference

19 August 2017

Il-Young Kweon

7

1 reference

19 August 2017

William M O'Neil

8

1 reference

19 August 2017

Tapan K Saikia

9

1 reference

19 August 2017

Jianxiang Wang

10

1 reference

19 August 2017

20 December 2008

1 reference

International Journal of Hematology

19 August 2017

1 reference

19 August 2017

89

1 reference

19 August 2017

14-23

1 reference

19 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-008-0230-0

19 August 2017

0 references

cites work

Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand

1 reference

12 December 2020

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

12 December 2020

Recommendations of the canadian consensus group on the management of chronic myeloid leukemia

1 reference

12 December 2020

[HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases]

1 reference

12 December 2020

1 reference

12 December 2020

Resistance to targeted therapy in chronic myelogenous leukemia

1 reference

12 December 2020

Assessment of the future resources and needs for hospitalization in Hong Kong SAR (Special Administrative District)

1 reference

12 December 2020

[Preliminary study of HLA haplotype matched and T-cell undepleted allogeneic bone marrow transplantation for treatment of leukemia]

1 reference

12 December 2020

Treatment of 54 chronic myelogenous leukemia with Gleevec

1 reference

12 December 2020

Multivariate analysis of prognostic factors in chronic myelogenous leukemia.

1 reference

12 December 2020

Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations

1 reference

12 December 2020

Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha

1 reference

12 December 2020

Imatinib mesylate (STI-571) and porphyria cutanea tarda in a Chinese patient.

1 reference

12 December 2020

Imatinib mesylate in chronic myeloid leukemia: a prospective, single arm, non-randomized study.

1 reference

12 December 2020

Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience

1 reference

12 December 2020

Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal

1 reference

12 December 2020

Comparison of allele specific oligonucleotide-polymerase chain reaction and direct sequencing for high throughput screening of ABL kinase domain mutations in chronic myeloid leukemia resistant to imatinib.

1 reference

12 December 2020

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

12 December 2020

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

1 reference

12 December 2020

Chronic myelogenous leukaemia (CML): an update

1 reference

12 December 2020

Multivariate analysis of prognostic factors in Philadelphia chromosome-positive chronic granulocytic leukemia

1 reference

12 December 2020

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

12 December 2020

Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation

1 reference

12 December 2020

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

12 December 2020

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

12 December 2020

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

12 December 2020

Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefits

1 reference

12 December 2020

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

12 December 2020

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

1 reference

12 December 2020

10.1007/S12185-008-0230-0

Identifiers

DOI

1 reference

19 August 2017

1 reference